Simplex Trading’s MaxCyte MXCT Stock Holding History

Simplex Trading’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,900	Closed	-$4.5K	–	9769
2025 Q4	$4.5K	Sell	2,900 -2,000	-41%	-$3.19K	﹤0.01%	7490
2025 Q3	$7K	Buy	+4,900	New	+$8.52K	﹤0.01%	8124
2025 Q2	–	Sell	-600	Closed	-$1K	–	9357
2025 Q1	$1K	Sell	600 -11,100	-95%	-$43.8K	﹤0.01%	8252
2024 Q4	$48K	Buy	+11,700	New	+$44.2K	﹤0.01%	5911
2023 Q2	–	Sell	-400	Closed	-$1K	–	9575
2023 Q1	$1K	Buy	+400	New	+$1.97K	﹤0.01%	8727
2022 Q4	–	Sell	-2,400	Closed	-$15K	–	9958
2022 Q3	$15K	Sell	2,400 -3,400	-59%	-$19K	﹤0.01%	7834
2022 Q2	$27K	Buy	5,800 +400	+7%	+$1.97K	﹤0.01%	7256
2022 Q1	$37K	Buy	+5,400	New	+$36.9K	﹤0.01%	7540

Other funds holding MXCT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $641M AUM 61.79% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFM

Brooklands Fund Management London, United Kingdom $88.9M AUM

Simplex Trading's MXCT Position: Q1 2026 in Review

Simplex Trading opened a new position in MaxCyte (MXCT) in Q1 2026: 1,267 shares worth $890. The stake represents ﹤0.01% of the portfolio and ranks #8624 among its holdings. This is a return to the name: Simplex Trading previously reported a position in MXCT as recently as Q2 2025.

Simplex Trading first reported a position in MXCT in Q4 2022 and has held it in 9 quarters since. The position peaked at $13K in Q3 2024. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

Simplex Trading held 1,267 shares of MaxCyte worth $890 as of Q1 2026.
MaxCyte was a new Simplex Trading position in Q1 2026.
MaxCyte made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8624 holding.
Simplex Trading first reported a position in MaxCyte in Q4 2022 and has held it in 9 quarters since.
Simplex Trading's MaxCyte position peaked at $13K in Q3 2024.
130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.